- Home
- OPT vs TIPT Comparison
OPT vs TIPT Comparison
Compare OPT & TIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPT
- TIPT
- Stock Information
- Founded
- OPT 1984
- TIPT 2007
- Country
- OPT Australia
- TIPT United States
- Employees
- OPT N/A
- TIPT N/A
- Industry
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- TIPT Property-Casualty Insurers
- Sector
- OPT Health Care
- TIPT Finance
- Exchange
- OPT Nasdaq
- TIPT Nasdaq
- Market Cap
- OPT 767.9M
- TIPT 803.7M
- IPO Year
- OPT 2020
- TIPT 2007
- Fundamental
- Price
- OPT $3.60
- TIPT $21.31
- Analyst Decision
- OPT Strong Buy
- TIPT
- Analyst Count
- OPT 1
- TIPT 0
- Target Price
- OPT $12.00
- TIPT N/A
- AVG Volume (30 Days)
- OPT 9.2K
- TIPT 70.4K
- Earning Date
- OPT 08-30-2024
- TIPT 10-30-2024
- Dividend Yield
- OPT N/A
- TIPT 2.30%
- EPS Growth
- OPT N/A
- TIPT 357.81
- EPS
- OPT N/A
- TIPT 0.97
- Revenue
- OPT $261,859.00
- TIPT $1,985,630,000.00
- Revenue This Year
- OPT N/A
- TIPT N/A
- Revenue Next Year
- OPT $46,864.64
- TIPT N/A
- P/E Ratio
- OPT N/A
- TIPT $21.81
- Revenue Growth
- OPT N/A
- TIPT 27.40
- 52 Week Low
- OPT $1.79
- TIPT $14.96
- 52 Week High
- OPT $5.45
- TIPT $24.09
- Technical
- Relative Strength Index (RSI)
- OPT 52.65
- TIPT 50.42
- Support Level
- OPT $3.15
- TIPT $19.80
- Resistance Level
- OPT $3.39
- TIPT $21.58
- Average True Range (ATR)
- OPT 0.17
- TIPT 0.65
- MACD
- OPT 0.05
- TIPT -0.11
- Stochastic Oscillator
- OPT 72.31
- TIPT 62.92
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
About TIPT Tiptree Inc.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. Company has non reportable segment such as Tiptree Capital - Other and Corporate. It generates maximum revenue from the Insurance segment. The insurance segment provides specialty insurance, warranty products and related administration services; and the Mortgage segment originates, sell and service conventional, conforming agency and government-insured residential mortgage loans. Tiptree Capital - Other is the remainder of companies operations aggregated from mortgage and insurance. Corporate activities include holding company interest expense, corporate employee compensation and benefits, and other expenses.